Preoperative Oral Magnesium to Prevent Postoperative Atrial Fibrillation Following Coronary Surgery (POMAF-CS)
Status:
Completed
Trial end date:
2019-10-20
Target enrollment:
Participant gender:
Summary
Post operative atrial fibrillation following coronary surgery (POAF) is a common complication
that can affect 10-50% of patients.
Intravenous magnesium, administered per-or post-operatively, reduces the incidence of POAF.
However, the effect of preoperative magnesium loading on the incidence of POAF is not yet
studied.
200 patients admitted for elective coronary surgery under Cardiopulmonary bypass will be
included in this prospective randomized controlled trial.
Treatment group will receive preoperative oral magnesium and control group will receive
placebo for 3 days before the planned coronary artery surgery.
The occurrence of POAF will be studied as a main outcome.